Execution of the legal contract for Terrain’s U.S. sales partnership for Bondlido is delayed to within 2026. Initial shipment is scheduled for November. Launch preparations are proceeding in parallel and the expected launch remains within 2026. Impact on the fiscal year ending December 2026 is expected to be minimal.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4586","jir_company_name":"MedRx Co., Ltd","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4586-20261030-01.pdf","jir_short_summary":"Execution of the legal contract for Terrain's U.S. sales partnership for Bondlido is delayed to within 2026. Initial shipment is scheduled for November. Launch preparations are proceeding in parallel and the expected launch remains within 2026. Impact on the fiscal year ending December 2026 is expected to be minimal.","jir_summary":"### Progress of Partnership and Launch Preparations\nRegarding Bondlido, a lidocaine patch product for the U.S. market, MedRx Co., Ltd is finalizing the contractual conditions for a U.S. sales license with Terrain Pharmaceuticals, and finalizing those contract terms is taking additional time. As of September 30, the expected execution has been revised to within 2026, and the initial shipment is scheduled to be delivered to Terrain in November. Launch preparations are progressing in parallel, and the expected launch timing remains within 2026.\n\n### Market Outlook, Impact and Next Steps\nBondlido is a novel lidocaine topical patch using ILTS technology, and synergistic effects in the U.S. market are anticipated. Assuming future increases in sales volume, the contract terms are expected to reflect provisions for increased production and cost-sharing. At this time, the impact on the fiscal year ending December 2026 is expected to be minimal, and launch preparations and the start of sales will proceed in parallel.","jir_financial_highlights":"Expected execution of Bondlido sales license agreement: within 2026 (Unknown)\nInitial shipment scheduled: November (Unknown)\nImpact on fiscal year ending December 2026: Minimal (Unknown)","jir_category":"","jir_hashtags":"#BondlidoPartnership, #Terrain, #LidocainePatch","jir_key_figures":"Expected execution of Bondlido sales license agreement: within 2026\nInitial shipment: November 2026\nImpact on fiscal year ending December 2026: Minimal","jir_meta_title":"MedRx Co., Ltd \u2014 Progress of U.S. Bondlido Partnership and Launch Timing\uff5cExpected within 2026","jir_meta_description":"Latest update on the sales partnership negotiations with Terrain in the U.S. for Bondlido and the expected launch timing. Initial shipment is scheduled for November, contract execution targeted within 2026, and impact on the fiscal year ending December 2026 is minimal.","jir_og_title":"Progress of U.S. Bondlido Partnership and Launch Timing\uff5cMedRx Co., Ltd","jir_og_description":"Report on progress of the sales partnership with Terrain and outlook for launch timing. Initial shipment scheduled for November; contract execution targeted within 2026. Impact on fiscal year ending December 2026 is minimal.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59495,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"corporate_restructuring","footnotes":""},"sector":[],"importance":[],"class_list":["post-138900","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n